{
    "name": "Types of manufactured cannabis products",
    "number": "10",
    "text": "(a)\u00a0 The types of medical cannabis products that may be manufactured and distributed pursuant to this chapter shall be limited to:\n\u00a0\u00a0\u00a0\u00a0 (1)\u00a0 Capsules;\n\u00a0\u00a0\u00a0\u00a0 (2)\u00a0 Lozenges;\n\u00a0\u00a0\u00a0\u00a0 (3)\u00a0 Pills;\n\u00a0\u00a0\u00a0\u00a0 (4)\u00a0 Oils and oil extracts;\n\u00a0\u00a0\u00a0\u00a0 (5)\u00a0 Tinctures;\n\u00a0\u00a0\u00a0\u00a0 (6)\u00a0 Ointments and skin lotions;\n\u00a0\u00a0\u00a0\u00a0 (7)\u00a0 Transdermal patches;\n\u00a0\u00a0\u00a0\u00a0 (8)\u00a0 Pre-filled and sealed containers used to aerosolize and deliver cannabis orally, such as with an inhaler or nebulizer; and\n\u00a0\u00a0\u00a0\u00a0 (9)\u00a0 Other products as specified by the department.\n\u00a0\u00a0\u00a0\u00a0 (b)\u00a0 As used in this section, \"lozenge\" means a small tablet manufactured in a manner to allow for the dissolving of its medicinal or therapeutic component slowly in the mouth. [L 2015, c 241, pt of \u00a72; am L 2016, c 230, \u00a717; am L 2017, c 170, \u00a72]\n\u00a0\nRevision Note\n\u00a0\n\u00a0 In subsection (a)(8), \"marijuana\" changed to \"cannabis\" to conform to L 2017, c 170, pursuant to \u00a723G-15."
}